204 related articles for article (PubMed ID: 34730056)
1. Metronomic delivery of orally available pemetrexed-incorporated colloidal dispersions for boosting tumor-specific immunity.
Maharjan R; Subedi L; Pangeni R; Jha SK; Kang SH; Chang KY; Byun Y; Choi JU; Park JW
Drug Deliv; 2021 Dec; 28(1):2313-2328. PubMed ID: 34730056
[TBL] [Abstract][Full Text] [Related]
2. Intestinal transport mechanism and in vivo anticancer efficacy of a solid oral formulation incorporating an ion-pairing complex of pemetrexed with deoxycholic acid derivative.
Pangeni R; Jha SK; Maharjan R; Choi JU; Chang KY; Choi YK; Byun Y; Park JW
Int J Nanomedicine; 2019; 14():6339-6356. PubMed ID: 31496690
[TBL] [Abstract][Full Text] [Related]
3. Enhanced oral absorption of pemetrexed by ion-pairing complex formation with deoxycholic acid derivative and multiple nanoemulsion formulations: preparation, characterization, and in vivo oral bioavailability and anticancer effect.
Pangeni R; Choi JU; Panthi VK; Byun Y; Park JW
Int J Nanomedicine; 2018; 13():3329-3351. PubMed ID: 29922055
[TBL] [Abstract][Full Text] [Related]
4. Anti-Angiogenic Effect of Orally Available Pemetrexed for Metronomic Chemotherapy.
Maharjan R; Pangeni R; Jha SK; Choi JU; Chang KY; Choi YK; Park JW; Byun Y
Pharmaceutics; 2019 Jul; 11(7):. PubMed ID: 31337061
[TBL] [Abstract][Full Text] [Related]
5. Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer.
Mahmud F; Jeon OC; Alam F; Maharjan R; Choi JU; Park J; Lee S; Park JW; Lee DS; Byun Y
J Control Release; 2018 Aug; 284():160-170. PubMed ID: 29908222
[TBL] [Abstract][Full Text] [Related]
6. A novel oral metronomic chemotherapy provokes tumor specific immunity resulting in colon cancer eradication in combination with anti-PD-1 therapy.
Maharjan R; Choi JU; Kweon S; Pangeni R; Lee NK; Park SJ; Chang KY; Park JW; Byun Y
Biomaterials; 2022 Feb; 281():121334. PubMed ID: 34974206
[TBL] [Abstract][Full Text] [Related]
7. Improvements in the Oral Absorption and Anticancer Efficacy of an Oxaliplatin-Loaded Solid Formulation: Pharmacokinetic Properties in Rats and Nonhuman Primates and the Effects of Oral Metronomic Dosing on Colorectal Cancer.
Pangeni R; Subedi L; Jha SK; Kweon S; Kang SH; Chang KY; Choi JU; Byun Y; Park JW
Int J Nanomedicine; 2020; 15():7719-7743. PubMed ID: 33116497
[TBL] [Abstract][Full Text] [Related]
8. Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management.
Mahmud F; Chung SW; Alam F; Choi JU; Kim SW; Kim IS; Kim SY; Lee DS; Byun Y
J Control Release; 2017 Mar; 249():42-52. PubMed ID: 28093298
[TBL] [Abstract][Full Text] [Related]
9. Encapsulation in a rapid-release liposomal formulation enhances the anti-tumor efficacy of pemetrexed in a murine solid mesothelioma-xenograft model.
Eldin NE; Abu Lila AS; Kawazoe K; Elnahas HM; Mahdy MA; Ishida T
Eur J Pharm Sci; 2016 Jan; 81():60-6. PubMed ID: 26415830
[TBL] [Abstract][Full Text] [Related]
10. Modulating tumor immunity by metronomic dosing of oxaliplatin incorporated in multiple oral nanoemulsion.
Choi JU; Maharjan R; Pangeni R; Jha SK; Lee NK; Kweon S; Lee HK; Chang KY; Choi YK; Park JW; Byun Y
J Control Release; 2020 Jun; 322():13-30. PubMed ID: 32169534
[TBL] [Abstract][Full Text] [Related]
11. Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamide.
Weir GM; Hrytsenko O; Quinton T; Berinstein NL; Stanford MM; Mansour M
J Immunother Cancer; 2016; 4():68. PubMed ID: 27777777
[TBL] [Abstract][Full Text] [Related]
12. Immune modulation of the liver metastatic colorectal cancer microenvironment via the oral CAPOX-mediated cGAS-STING pathway.
Park SJ; Kweon S; Moyo MK; Kim HR; Choi JU; Lee NK; Maharjan R; Cho YS; Park JW; Byun Y
Biomaterials; 2024 Oct; 310():122625. PubMed ID: 38820768
[TBL] [Abstract][Full Text] [Related]
13. Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy.
Chen J; Yang X; Huang L; Lai H; Gan C; Luo X
Drug Deliv; 2018 Nov; 25(1):1932-1942. PubMed ID: 30472899
[TBL] [Abstract][Full Text] [Related]
14. Combining Albumin-Binding Properties and Interaction with Pemetrexed to Improve the Tissue Distribution of Radiofolates.
Müller C; Guzik P; Siwowska K; Cohrs S; Schmid RM; Schibli R
Molecules; 2018 Jun; 23(6):. PubMed ID: 29914162
[TBL] [Abstract][Full Text] [Related]
15. Advanced therapeutic approach for the treatment of malignant pleural mesothelioma via the intrapleural administration of liposomal pemetrexed.
Ando H; Kobayashi S; Abu Lila AS; Eldin NE; Kato C; Shimizu T; Ukawa M; Kawazoe K; Ishida T
J Control Release; 2015 Dec; 220(Pt A):29-36. PubMed ID: 26476173
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the tumor microenvironment by intratumoral administration of IMO-2125, a novel TLR9 agonist, for cancer immunotherapy.
Wang D; Jiang W; Zhu F; Mao X; Agrawal S
Int J Oncol; 2018 Sep; 53(3):1193-1203. PubMed ID: 29956749
[TBL] [Abstract][Full Text] [Related]
17. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.
Tongu M; Harashima N; Monma H; Inao T; Yamada T; Kawauchi H; Harada M
Cancer Immunol Immunother; 2013 Feb; 62(2):383-91. PubMed ID: 22926062
[TBL] [Abstract][Full Text] [Related]
18. The Folate Pathway Inhibitor Pemetrexed Pleiotropically Enhances Effects of Cancer Immunotherapy.
Schaer DA; Geeganage S; Amaladas N; Lu ZH; Rasmussen ER; Sonyi A; Chin D; Capen A; Li Y; Meyer CM; Jones BD; Huang X; Luo S; Carpenito C; Roth KD; Nikolayev A; Tan B; Brahmachary M; Chodavarapu K; Dorsey FC; Manro JR; Doman TN; Donoho GP; Surguladze D; Hall GE; Kalos M; Novosiadly RD
Clin Cancer Res; 2019 Dec; 25(23):7175-7188. PubMed ID: 31409612
[TBL] [Abstract][Full Text] [Related]
19. Enhanced antitumor efficacy of bile acid-lipid complex-anchored docetaxel nanoemulsion via oral metronomic scheduling.
Jha SK; Chung JY; Pangeni R; Choi HS; Subedi L; Kweon S; Choi JU; Byun Y; Kim YH; Park JW
J Control Release; 2020 Dec; 328():368-394. PubMed ID: 32890552
[TBL] [Abstract][Full Text] [Related]
20. Liposomal pemetrexed: formulation, characterization and in vitro cytotoxicity studies for effective management of malignant pleural mesothelioma.
Essam Eldin N; Elnahas HM; Mahdy MA; Ishida T
Biol Pharm Bull; 2015; 38(3):461-9. PubMed ID: 25757929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
